Clinical Review - Renal colic
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
An EMA is defined as a non-surgical termination of an early pregnancy before 63 days using a combination of the drugs mifepristone and misoprostol.
Current law states that women must make two visits to a hospital with the second visit solely because the law specifies that an abortion may only be carried out in hospitals or a specially approved location.
But Ann Furedi, chief executive of the British Pregnancy Advisory Service, told delegates at the Future of Abortion conference in central London yesterday that the current law hindered women from accessing EMAs because it was framed in the 1960s when modern treatments such as abortion drugs for home use were not available.
She added: ‘Women should not have to make two trips to an abortion service. Instead they should be able to take the medication home and be followed up with telephone support.'
Health minister Dawn Primarolo, added that there had been a shift towards EMAs with 35 per cent of all abortion in 2007 being EMAs.
But she warned that it was important to make sure that women felt safe about having an EMA outside of hospital.
‘For this reason we will be seeking views on this and on a draft protocol with service providers and users, before we move ahead,' she said.
Amendments will also be put forward to allow EMAs to be carried out in community settings such as polyclinics and GP surgeries and to remove the need for two doctors' signatures when agreeing an abortion. The amendments are expected to be put forward early next month.
sanjay.tanday@haymarket.com
Future of Abortion website
Editors blog: Why is Britain teetering on the verge of becoming the abortion capital of the world?
Comment below and tell us what you think
Quick search - use * for an abbreviated search, eg nico*
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more
Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more
Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more
Comments
Only registered users may comment. Log in now or register for a free account.